Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FENC Fennec Pharmaceuticals Inc.

盘前交易 12-23 09:19:49 EST

5.99

+0.15

+2.57%

最高5.99	最低5.73	成交量17.29万
今开5.73	昨收5.84	日振幅4.45%
总市值1.64亿	流通市值7,813万	总股本2,743万
成交额102.32万	换手率1.33%	流通股本1,304万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":5.99,"timestamp":1734728400000,"preClose":5.84,"halted":0,"volume":172932,"delay":0,"floatShares":13042805,"shares":27427704,"eps":-0.041639,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.15,"latestTime":"12-23 09:19:49 EST","open":5.73,"high":5.99,"low":5.73,"amount":1023213.292169,"amplitude":0.044521,"askPrice":6.28,"askSize":100,"bidPrice":5.55,"bidSize":159,"shortable":3,"etf":0,"ttmEps":-0.041639,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":5.99,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.99,"preClose":5.99,"latestTime":"19:26 EST","volume":27227,"amount":163091.28,"timestamp":1734740773491},"volumeRatio":2.226416450653275,"impliedVol":0.0263,"impliedVolPercentile":0.072},"requestUrl":"/m/hq/s/FENC","defaultTab":"news","newsList":[{"id":"2492100045","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.30%报5.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492100045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492100045?lang=zh_cn&edition=full","pubTime":"2024-12-20 03:00","pubTimestamp":1734634853,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日03时00分，Fennec Pharmaceuticals Inc.股票出现异动，股价快速拉升5.30%。截至发稿，该股报5.96美元/股，成交量3.7651万股，换手率0.14%，振幅6.54%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.涨幅较大，Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为8458.05%、2483.67%、624.65%，振幅较大的相关个股有Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为396.08%、307.92%、249.61%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220030054a1fbc095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220030054a1fbc095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2489752234","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨5.42%报6.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489752234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489752234?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:21","pubTimestamp":1733498462,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时21分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅上涨5.42%。截至发稿，该股报6.03美元/股，成交量8940股，换手率0.03%，振幅5.24%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232103971c275b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232103971c275b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2489846850","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘大幅下挫5.16%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489846850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489846850?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:00","pubTimestamp":1733410850,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时00分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.16%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为2162.32%、316.51%、282.97%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Protara Therapeutics, Inc.，振幅分别为109.60%、84.26%、76.84%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523005198e59f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523005198e59f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2488064616","title":"Fennec Pharmaceuticals Inc.盘中异动 临近午盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488064616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488064616?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:53","pubTimestamp":1733158386,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时53分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.45%。截至发稿，该股报6.39美元/股，成交量11.4606万股，换手率0.42%，振幅6.93%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为2136.51%、2071.05%、256.14%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为481.02%、289.12%、64.17%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203005306abf04652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203005306abf04652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2486964888","title":"Fennec Pharmaceuticals Inc.盘中异动 快速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486964888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486964888?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:51","pubTimestamp":1732636289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时51分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.30%。截至发稿，该股报5.96美元/股，成交量2.5162万股，换手率0.09%，振幅8.09%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Poseida Therapeutics, Inc.、Protagenic Therapeutics, Inc.、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为36.62%、23.54%、21.21%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、34.09%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235129971a8acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235129971a8acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2486403096","title":"Fennec Pharmaceuticals Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486403096?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:45","pubTimestamp":1732553116,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时45分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速拉升5.08%。截至发稿，该股报5.59美元/股，成交量6.8801万股，换手率0.25%，振幅8.36%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.65%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Exicure, Inc.涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为124.22%、104.78%、79.50%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为95.05%、81.74%、75.84%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004516abde38ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004516abde38ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2484148403","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148403?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:59","pubTimestamp":1732114756,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时59分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.03%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为933.70%、416.57%、167.47%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为183.66%、102.78%、65.87%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670710661.SGD","BK4077","LOVE","RDDT","QS","MOS","EFX","CPRX","BECN","ACRS","BK4113","KHC","CPRT","PTCT","CASY","IDYA","EHAB","LU2249611893.SGD","BK4588","MRNA","KYMR","LU2326559502.SGD","CHPT","CGEM","BK4585","MSTR","PANW","FNV","PLUG","BK4107","FENC","NFLX","RC","LU1046421795.USD","VRT","LU0106261372.USD","LU0109394709.USD","WSM","CCCC","DCOM","LU2237957902.USD","MEOH","LU1429558221.USD","ARVN","IE00BQXX3C00.GBP","RGNX","LU1571399168.USD","KMPR","FTNT"],"gpt_icon":1},{"id":"2484854813","title":"Fennec Pharmaceuticals Inc.2024财年第三财季实现净利润-5.74百万美元，同比减少206.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484854813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484854813?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772991,"startTime":"0","endTime":"0","summary":"11月17日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2024财年第三财季净利润为-5.74百万美元，同比减少206.95%；其中营业收入为6.97百万美元，同比增加6.90%，每股基本收益为-0.21美元。机构评级：截至2024年11月17日，当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为13.25美元，其中最低目标价为12.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2483396378","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483396378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483396378?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:29","pubTimestamp":1731515396,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时29分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅上涨5.44%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为481.74%、286.13%、103.74%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为88.00%、67.77%、46.01%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2481198320","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.00%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198320?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报5.04美元/股，成交量363股，换手率0.00%，振幅0.00%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Macrogenics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Syndax Pharmaceuticals, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1007.84%、97.66%、46.60%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Ocular Therapeutix, Inc.、诺瓦瓦克斯医药，振幅分别为104.05%、103.88%、96.82%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2481536522","title":"Fennec Pharmaceuticals Inc.盘中异动 临近午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481536522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481536522?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:33","pubTimestamp":1730738004,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时33分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速上涨5.07%。截至发稿，该股报4.56美元/股，成交量2.4769万股，换手率0.09%，振幅6.22%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为322.05%、272.26%、73.27%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2480881599","title":"Fennec Pharmaceuticals Inc   预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881599","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881599?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:00","pubTimestamp":1730469651,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的618万美元增长42.6%，达到882.1万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期是每股亏损 10 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 15.00 美元，高于其最新收盘价 4.36 美元。11月1日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Fennec Pharmaceuticals Inc   预计每股亏损 10 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2478486244","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨7.55%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486244?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:36","pubTimestamp":1730122617,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时36分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升7.55%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为549.74%、48.81%、37.01%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monopar Therapeutics Inc.、Calidi Biotherapeutics, Inc.，振幅分别为34.60%、18.55%、18.35%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821365798e3ed05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821365798e3ed05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2478196513","title":"Fennec Pharmaceuticals Inc.盘中异动 快速下跌5.24%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478196513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478196513?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:38","pubTimestamp":1729885090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时38分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速跳水5.24%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为866.68%、793.64%、434.91%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026033810ab74a1c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026033810ab74a1c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2474208488","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474208488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474208488?lang=zh_cn&edition=full","pubTime":"2024-10-10 02:50","pubTimestamp":1728499832,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日02时50分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.10%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为725.51%、551.26%、249.20%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002503398e3b860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002503398e3b860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2472334642","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.00%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472334642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472334642?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:39","pubTimestamp":1727717949,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时39分，Fennec Pharmaceuticals Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报4.94美元/股，成交量1.7101万股，换手率0.06%，振幅4.53%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001013910ab672fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001013910ab672fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2470769987","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470769987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470769987?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:00","pubTimestamp":1727377220,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时00分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.36%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Pasithea Therapeutics Corp.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃，换手率分别为5302.15%、178.28%、115.45%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp.，振幅分别为79.84%、75.67%、54.10%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927030021ab663a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927030021ab663a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2460503422","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460503422","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460503422?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074288,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.22%。截至发稿，该股报5.27美元/股，成交量8245股，换手率0.03%，振幅4.50%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为1882.53%、1334.79%、295.45%，振幅较大的相关个股有Virax Biolabs Group Limited、Theriva Biologics, Inc.、Alzamend Neuro, Inc.，振幅分别为34.74%、31.36%、24.51%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921312898e35566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921312898e35566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2460837710","title":"Fennec Pharmaceuticals Inc.2024财年第二财季实现净利润-5.55百万美元，同比减少2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460837710","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460837710?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:04","pubTimestamp":1723997066,"startTime":"0","endTime":"0","summary":"8月19日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.55百万美元，同比减少2.02%；其中营业收入为7.26百万美元，同比增加118.02%，每股基本收益为-0.20美元。机构评级：截至2024年8月19日，当前有6家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为15.83美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900044395a386b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900044395a386b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.2909},{"period":"3month","weight":0.1431},{"period":"6month","weight":-0.067},{"period":"1year","weight":-0.4306},{"period":"ytd","weight":-0.4661}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的，其名称是“粘着”技术公司，随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司，以及加拿大的一家加拿大公司(简称“CBI”)，在这里被统称为“公司”，是一家生物制药公司，有一个正在开发中的产品，用于治疗癌症。该公司是一家生物制药公司，主要关注硫代硫酸钠(“STS”)的开发，以预防小儿癌症患者体内铂中毒的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.031154},{"month":6,"riseRate":0.428571,"avgChangeRate":0.018884},{"month":7,"riseRate":0.714286,"avgChangeRate":0.031531},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.050899},{"month":9,"riseRate":0.571429,"avgChangeRate":0.035762},{"month":10,"riseRate":0.375,"avgChangeRate":-0.005151},{"month":11,"riseRate":0.75,"avgChangeRate":0.046419},{"month":12,"riseRate":0.5,"avgChangeRate":0.031818}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}